BioCentury
ARTICLE | Clinical News

AYX1: Phase II started

July 21, 2014 7:00 AM UTC

Adynxx began the double-blind, placebo-controlled, U.S. Phase II ADYX-003 trial to evaluate single intrathecal injections of 660 and 1,100 mg AYX1 given prior to unilateral total knee replacement in a...